Child and Parental Characteristics of Medication Use for Attention-Deficit/Hyperactivity Disorder
Beate Oerbeck1, Kari Furu2, Pal Zeiner1
1Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Insights
Medication use for attention-deficit/hyperactivity disorder (ADHD) in children is primarily linked to child characteristics, not parental factors. This large study found that disruptive symptoms at age 3 predicted medication use for ADHD.
Area of Science:
- Pediatric Psychiatry
- Neurodevelopmental Disorders
- Pharmacological Treatments
Background:
- Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder affecting children.
- Understanding factors associated with ADHD medication use is crucial for effective treatment strategies.
- Previous research has explored both child and parental characteristics influencing treatment decisions.
Purpose of the Study:
- To investigate child and parental characteristics associated with medication use in children diagnosed with ADHD.
- To compare characteristics between medicated and unmedicated children with ADHD within a large prospective cohort.
Main Methods:
- Utilized data from the Norwegian Mother, Father and Child Cohort Study (MoBa) linked to prescription and patient registries.
- Analyzed data from 1,764 children with ADHD (ICD-10: F90, F98.8) between 2008-2013.
- Compared child characteristics (including early disruptive and ADHD symptoms) and parental factors between medicated and unmedicated groups.
Main Results:
- 77% of children with ADHD used medication, with no gender difference in medication use or age at first prescription.
- Medicated children showed significantly more hyperkinetic conduct disorders and lower global functioning.
- Higher disruptive symptoms at age 3 were significantly associated with medication use; ADHD symptoms at age 3 were close to significant.
Conclusions:
- Child characteristics, particularly early disruptive symptoms, are significantly associated with ADHD medication use.
- Parental factors like education and psychopathology did not significantly predict medication use in this cohort.
- Established clinical practices likely influence medication prescription, especially for hyperkinetic conduct disorder in a high-income setting.
Abstract:
To investigate child and parental characteristics of medication use for attention-deficit/hyperactivity disorder (ADHD). Participants were part of the prospective population-based Norwegian Mother, Father and Child Cohort study (MoBa) (n = 114,500 children, 95,000 mothers, and 75,000 fathers). This cohort was linked to the Norwegian Prescription Database (NorPD) and the Norwegian Patient Registry (NPR) to compare child and parental characteristics in children medicated and not medicated for ADHD during years 2008-2013. One thousand seven hundred and sixty-four children (74% boys) with ADHD (International Classification of Diseases [ICD-10]: F90 and F98.8) were identified. One thousand three hundred and sixty-two (77%) used medication. Boys and girls did not differ in the use of ADHD medication (both 77%). Mean age at first prescription was 9 years in both boys and girls, and age at ADHD diagnosis was 8 years in medicated and unmedicated children. Significantly more hyperkinetic conduct disorders (F90.1), and significantly fewer with attention-deficit disorder (F98.8) were found among the medicated children compared to the unmedicated children. The medicated children also had a significantly lower global functioning (Child Global Assessment Scale). Child disruptive symptoms reported in the MoBa child age 3 year questionnaire were significantly higher in children who used medication compared to the nonusers (t = 2.2, p = 0.03), and group differences in ADHD symptoms at age 3 years were close to significant (t = 1.8, p = 0.07). Other preschool child and parental characteristics were not significantly different in the two groups. In this large birth cohort study, where a great majority of children with ADHD used medication, only child characteristics were significantly associated with the use of medication. We could not replicate previous findings suggesting that "environmental factors," such as parental education and psychopathology, drive medication use. The small differences between medicated and unmedicated children in this cohort study, where a majority used medication, might be due to strong established clinical practices where medication is offered as a treatment option, particularly for hyperkinetic conduct disorder in an egalitarian high-income society.
More Related Videos
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Conduct Disorder
Oppositional Defiant Disorder
Diagnostic Criteria and...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Drug Therapy
Antianxiety Medications
Drug Dosing: Infants and Children
